J.&J.’s vaccine should carry warning of potential risk for rare blood clots, the E.U.’s regulator says, but believes benefits outweigh risks.


By BY MATINA STEVIS-GRIDNEFF from NYT World https://ift.tt/3sAXFNa

No comments:

Post a Comment